VirologyNews.net

Virology Xagena

Xagena Mappa
Medical Meeting
Dermabase.it
Cardiobase

Even with effective anti-HIV therapies, physicians still have not been able to eradicate the virus from infected individuals who are receiving such treatments, largely because of the persistence of HI ...


Studies 102 and 103 have compared Viread ( Tenofovir disoproxil ) to Hepsera ( Adefovir dipivoxil ) among patients with HBeAg-negative chronic hepatitis B and patients with HBeAg-positive hepatitis B, ...


Treatment with an investigational drug that induces the release of growth hormone significantly improved the symptoms of HIV lipodystrophy, a condition involving the redistribution of fat and other me ...


A preliminary study suggests there may be hope in the offing for some sufferers of chronic fatigue syndrome ( CSF ) with a new therapy being tested by researchers at the Stanford University School of ...


Stopping antiretroviral therapy in HIV-infected patients from time to time could reduce the side effects and costs of the treatment. Though extremely effective at preventing AIDS, lifelong treatmen ...


Researchers at the University of Illinois at Chicago and two other institutions have unraveled the structure of an important new drug target from the virus that causes SARS, severe acute respiratory s ...


A study has examined the function of a protein called HBZ, which is made by the human T cell leukemia virus type 1 ( HTLV-1 ), a retrovirus. The findings showed that HBZ enhances the ability of HTLV- ...


Researchers from the University of Massachusetts and the University of Pennsylvania have shown that race/ethnicity is a predictor of plasma lipids in patients with HIV-1 on HAART ( Highly Active AntiR ...


The human body has a unique immune system response to foreign DNA, suggesting that DNA viruses and RNA viruses are detected by different mechanisms. Yale School of Medicine researchers also found t ...


The data from a phase I/II study showed significant reductions in viral load among HIV-positive patients receiving GS 9137, or JTK-303, a novel oral HIV integrase inhibitor, as monotherapy or in comb ...


Researchers at Johns Hopkins say an infected person's HIV subtype is a better predictor than viral load for determining rapid death from AIDS. Traditional testing standards help monitor the progress ...


Researchers at Johns Hopkins and other institutions has found that a once-daily combination of three antiretroviral drugs works better as an initial treatment for HIV infection than another three-drug ...


The enrollment into a large international HIV/AIDS trial comparing continuous antiretroviral therapy with episodic drug treatment guided by levels of CD4+ cells has been stopped. Enrollment was sto ...


A genetic mutation that protects against HIV increases the risk of developing clinical West Nile Virus( WNV ) infection. . The mutation in question is a small deletion in a gene that encodes a prot ...


Some HIV medications lead to the development of drug-resistant HIV when patients take as few as two percent of their medications. For other medications, resistance occurs only when patients take most ...